Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Introduction
The serine-threonine kinase PDK1 (or PDPK1) is a key element of signaling transduction activated by extracellular ligands, which recognized as a key regulator of cell migration and chemotaxis by controlling numerous elements of signaling transduction and cytoskeletal dynamics. PDK1 has been proved to exist in different cell types and organisms including endothelial cells, mammary epithelial cells, smooth muscle cells, T lymphocytes and neutrophils. Furthermore, PDK1 gene ablation or silencing is associated with tumor progression in different cellular and experimental models.
PDK1 and the Cell Migration
PDK1 (an ancient and conserved protein kinase) is found throughout the entire eukaryotic domain, whose importance in vertebrates is reflected in its relevant physiological roles in embryonic development and adulthood. PDK1 is a member of the AGC kinase family (cAMP-dependent, cGMP-dependent and protein kinase C), which includes 60 serine-threonine kinases with a common phylogenetic origin. PDK1 is responsible for the phosphorylation and activation of several other AGC kinases, such as p70S6K, SGK, p90RSK and atypical PKC isoforms, and is initially characterized for the phosphorylation of Akt on threonine 308 in the activation loop, which is essential for its activation. PDK1 is mainly localized in the cytoplasm and able to translocate into the nucleus with a mechanism that involves the inhibition of its nuclear export sequence. Previous studies have shown that PDK1 can move to the plasma membrane, which is essential for its ability to regulate cell migration.
PDK1 and the Signaling Pathways of Cell Migration
It is reported that the binding of PDK1 to plasma membrane phospholipid PtdIns (3, 4, 5) P3 produced by means of PI3K activity is one prominent explanation of the relevant role of PDK1 in regulating cell migration. PDK1 and Akt share the ability to bind PtdIns (3,4,5) P3 through their PH domains. When they colocalize at the plasma membrane, PDK1 phosphorylates Akt activation loop on threonine 308. PAK1 can bind the small GTPases cdc42 and RAC1, which event could potentially colocalize PDK1 and PAK1 at the plasma membrane at the leading edge. Moreover, PAK1 was shown involved in the regulation of cell migration through its substrates LIMK, p41-ARC, filamin A.
PDK1 Control Different Hallmarks of Tumor Invasion
Tumors may be defined as a wide group of somatic diseases accompanied by the uncontrolled proliferation of cells. The ability to invade surrounding tissues is considered a distinctive feature of malign ones. It has been reported that PDK1 plays a crucial role in different processes involved in tumor invasion and dissemination. PI3K/PDK1/Akt signaling axis is also required to form functional invadopodia with proteolytic activity as shown by in vitro gelatin degradation, but PDK1 and Akt inhibition provides an effective tool to block invadopodia formation which is sustained by the active and oncogenic forms of p110α (E545K and H1047R). PDK1 is involved in the regulation of collective invasion in MCF10DCIS model of breast tumor by MRCKα signaling pathway, whose overexpression leads to the formation of multicellular invasive structures from MCF10DCIS spheroids in basement membrane gel.
Figure 1. PDK1 localizes at the leading edge of migrating cells by binding to PtdIns (3,4,5) P3 produced by PI3K. (http://dx.doi.org/10.1016/j.bbcan.2015.07.003)
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.